Inogen Inc. (INGN)
6.78
-0.36 (-5.04%)
At close: Mar 28, 2025, 3:59 PM
6.50
-4.13%
After-hours: Mar 28, 2025, 06:36 PM EDT
-5.04% (1D)
| Bid | 6.48 |
| Market Cap | 179.87M |
| Revenue (ttm) | 373.47M |
| Net Income (ttm) | -39.93M |
| EPS (ttm) | -1.52 |
| PE Ratio (ttm) | -4.46 |
| Forward PE | -7.63 |
| Analyst | Hold |
| Ask | 7.9 |
| Volume | 429,406 |
| Avg. Volume (20D) | 313,636 |
| Open | 7.14 |
| Previous Close | 7.14 |
| Day's Range | 6.67 - 7.33 |
| 52-Week Range | 6.14 - 13.33 |
| Beta | 1.16 |
About INGN
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the pa...
Industry Medical - Devices
Sector Healthcare
IPO Date Feb 14, 2014
Employees 766
Stock Exchange NASDAQ
Ticker Symbol INGN
Website https://www.inogen.com
Analyst Forecast
According to 2 analyst ratings, the average rating for INGN stock is "Hold." The 12-month stock price forecast is $7, which is an increase of 3.24% from the latest price.
Stock ForecastsNext Earnings Release
Inogen Inc. is scheduled to release its earnings on May 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-3.25%
Inogen shares are trading higher after the company...
Unlock content with
Pro Subscription
4 months ago
+17.23%
Inogen shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY24 revenue guidance.
